News - MFX

News

VoC reprot website

2026 Market Report – Process Development for Cell Therapies

Cross-sector insights into the challenges and opportunities for scalability and affordability in cell therapy development

Download

Press Releases

MFX is the Official Hardware Partner in the EcoCAR Consortium – An Innovate UK Sustainable Medicines Manufacturing Funded Collaboration

19 November 2025

MFX appoints Dr. Katy Newton as Chief Scientific Officer to drive innovation for cell-based therapies

18 March 2025

MFX, Tolemy Bio and Aminoacids.com Partner to Deliver Model-Driven Media Optimization for Cell and Gene Therapies

05 December 2024

View all press releases

Blog

99 problems in cell research – manual handling is number one

New technologies, old methods- Why 99% of cell culture vessels will never scale

How to ensure a consistent cell expansion process? Don’t start at the end

Footprint size matters in cell and gene therapy manufacturing

Is innovation in automation enough to drive cell therapy manufacturing optimization?

Why successful cell therapy processes need to scale both ways

Scale up, look sharp – why analytics in large-scale cell therapy manufacture is so difficult

Microfluidics- the perfect meeting-place for viruses and cells

Make your cells feel at home with microfluidics

How do you solve a problem like scaling up microfluidics?

Making cell therapies comPATible with large scale manufacturing

Data and Digitization – The key to better biology and more effective therapies

Newsfeed